Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 7/20 | 0.43 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | TGM2 | P21980 | 1/20 | 0.39 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.39 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8539753 | 0.94 | CTSD (0.39) | HTTFOLH1SIRT2CTSLCTSB | |
| SCHEMBL8534831 | 0.88 | HTT (0.46) | HTTFOLH1PTGER4 | |
| SCHEMBL8536372 | 0.86 | MMP2 (0.46) | CPB2 | |
| SCHEMBL7279640 | 0.83 | HTT (0.41) | HTTFOLH1PTGER4SIRT2CPB1 | |
| SCHEMBL8539750 | 0.82 | CTSD (0.42) | HTTFOLH1CTSLCTSBCTSS | |
| SCHEMBL7279627 | 0.81 | PTGER4 (0.41) | HTTFOLH1PTGER4 | |
| SCHEMBL8534869 | 0.80 | CTSD (0.58) | HTTFOLH1PTGER4 | |
| SCHEMBL6443882 | 0.78 | HTT (0.56) | HTTFOLH1SIRT2TGM2CPB1 | |
| SCHEMBL6443877 | 0.78 | HTT (0.56) | HTTFOLH1SIRT2TGM2CPB1 | |
| SCHEMBL9741444 | 0.77 | CTSD (0.37) | FOLH1SIRT2CPB1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |